# Hydromorphone for Perioperative Analgesia in Lung Tumor Ablation Parallel Controlled

> **NCT05848635** · PHASE4 · UNKNOWN · sponsor: **Qianfoshan Hospital** · enrollment: 88 (estimated)

## Conditions studied

- Pulmonary Nodule
- Ablation

## Interventions

- **DRUG:** Hydromorphone Hydrochloride
- **DRUG:** Morphine hydrochloride

## Key facts

- **NCT ID:** NCT05848635
- **Lead sponsor:** Qianfoshan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-05-01
- **Primary completion:** 2024-05-01
- **Final completion:** 2024-05-01
- **Target enrollment:** 88 (ESTIMATED)
- **Last updated:** 2023-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05848635

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05848635, "Hydromorphone for Perioperative Analgesia in Lung Tumor Ablation Parallel Controlled". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05848635. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*